AOE Annual Report (2021)

Greetings from Dr. Yin Li and editorial office of Annals of Esophagus (AOE).

Till Dec. 31, 2021, AOE has a total of 52 members on board, from 14 countries and published 44 articles in 2021 with 57% Review Article and 25% Original Article. Corresponding Authors were from 15 countries with USA, Canada, The Netherlands, and UK among the most. With joint effort and support, AOE has been accepted for inclusion in Scopus. According to the Google Analytics, AOE had an increasing number of pageviews and visitors (altogether 27,741 visitors worldwide and 77,531 pageviews last year). For more details, please check the below report.

Read More>>

Upper Esophageal Sphincter

This special series on Upper Esophageal Sphincter was edited by Dr. Fernando A. M. Herbella, from Federal University of São Paulo, São Paulo, Brazil.

Read More>>

Esophageal Cancer (Ongoing)

This special series on Esophageal Cancer is edited by Dr. Kenneth Meredith, from Florida State University College Of Medicine/Sarasota Memorial Health Care System, Sarasota, FL, USA.

Read More>>

Endoscopic Eradication Therapy in Barrett’s Esophagus

This special series guest edited by Dr. Madhav Desai aims to review existing standards, technologies and tools for endoscopic therapy of Barrett’s Esophagus with special focus on dysplasia and early neoplasia.

Read More>>

Management of Esophageal Perforations and Injuries and Other Benign Diseases

The aim of this series is to discuss the management of esophageal perforations, injuries and other benign diseases, reviewing the last updates in literature and providing the experts’ experience in clinical practice. A panel of international thoracic surgeons, general surgeons, and all expert in esophageal disease, was involved to present for each esophageal pathology the conservative or endoscopic and surgical treatments available. They also provided to the reader the best and the most appropriate approach to the specific cases on the basis of literature evidence and personal experiences.

Read More>>

Current Issues on GEJ Adenocarcinoma

Surgery is no longer the only way to treat this aggressive disease. A multimodal approach with preoperative chemo and chemo-radiotherapy is the standard care in most cases and the evaluation of the response to these treatments with new techniques such as MRI, represent a new field of investigation and development. Identification and prediction of response to various treatment modalities is a very promising field of research for proper patient selection. An important step forward has also been made with the development of endoscopic resection for early stage disease, avoiding “overtreatment”, leaving intact the esophageal function with a better long term quality of life.

Read More>>

Epidemiology, Biomarkers and Modelling of Gastroesophageal Reflux Disease

This special series on Epidemiology, Biomarkers and Modelling of Gastroesophageal Reflux Disease was co-edited by Dr. Peter W. Dettmar from Technostics Ltd & RD Biomed Ltd, Castle Hill Hospital, East Yorkshire, UK; and Dr. Jeffrey P. Pearson from Newcastle University Biosciences institute, The Medical School, Framlington Place, Newcastle upon Tyne, UK.

Read More>>

New Technologies in Esophageal Surgery and Endoscopy (Ongoing)

This special series on New Technologies in Esophageal Surgery and Endoscopy is co-edited by Dr. Abbas E. Abbas and Dr. Roman V. Petrov, from Temple University and Fox Chase Cancer Center, Philadelphia, PA, USA.

Read More>>